Loading clinical trials...

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms | Clinical Trials | Clareo Health

COMPLETEDPHASE2

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01

NCT03541200•Tanabe Pharma America, Inc.

View on ClinicalTrials.gov

Summary

An open-label, long term extension study of MT-8554 in postmenopausal women experiencing moderate to severe vasomotor symptoms who completed Study MT-8554-A01

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Signed informed consent to participate in this study.
•Subjects who complete the preceding trial (Study MT-8554-A01) through Week 12.

Exclusion Criteria

•Subjects who meet the withdrawal criteria for the proceeding trial (Study MT-8554-A01)

Locations (53)

Research Site

Birmingham, Alabama, United States

Research Site

Dothan, Alabama, United States

Research Site

Phoenix, Arizona, United States

Research Site

Norwalk, California, United States

Research Site

Sacramento, California, United States

Research Site

San Diego, California, United States

Research Site

Denver, Colorado, United States

Research Site

New London, Connecticut, United States

Research Site

Clearwater, Florida, United States

Research Site

Crystal River, Florida, United States

Key Dates

Start Date

April 18, 2018

Primary Completion Date

November 15, 2019

Completion Date

November 15, 2019

Last Updated

January 23, 2026

Enrollment

190

ACTUAL participants

Conditions

Vasomotor Symptoms (VMS)

Interventions

MT-8554

DRUG

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

NCT02049164

Vasomotor Symptoms (VMS)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 23, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions